weight loss drugs other than glp 1 Compound versions of GLP-1 for halted by FDA Guide to FDA-Approved Weight Loss

30 Furthermore, a comparative trial of exenatide and liraglutide in T2DM subjects concluded that both incretin mimetics were associated with a significant reduction in body weight when compared to baseline (2.87 kg and 3.24 kg, respectively)

Though there has been some preliminary data that GLP-1RAs might protect against cognitive decline and dementia, the research is still in clinical trials

It supports strength, mobility, insulin sensitivity, posture, balance, healthy aging, and long-term weight maintenance

Current Obesity Reports , 9(4), 522-532

Drafting the manuscript: C

The decision to continue, taper, or stop should be individualized, not driven by arbitrary timelines